# Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

> **NCT05766007** · — · COMPLETED · sponsor: **University of Liverpool** · enrollment: 168 (actual)

## Conditions studied

- Schizophrenia
- Psychosis
- Mania
- Pregnancy
- Drug Exposure in Utero
- Drug Exposure Via Breast Milk
- Antipsychotic Agents
- Breastfeeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05766007
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2025-11-21
- **Final completion:** 2025-11-21
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766007, "Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05766007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*